NOXAFIL susp 40 mg/ml fl 105 ml
7680578430015
CH-57843
J02AC04
08.06.0.
Reimbursement limitations:
NOXAFIL2
La prophylaxie chez des patients à risque élevé (voir 1a et 1b) peut être prescrit …
1 / 3
google
Details
- Product number
- 5784301
- CPT
- -
- Packaging group
- 105
- Unit
- ml
- Composition
- posaconazolum 40 mg, polysorbatum 80, glucosum liquidum, arom.: vanillinum et alia, conserv.: E 211, alcohol benzylicus, excipiens ad suspensionem pro 1 ml.
Articles (1)
Noxafil, Suspension zum Einnehmen
suspension
105
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
40.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AIMDK |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
Reimbursement information
Public price
CHF 627.15
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2007
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 57843
- Drug name
- Noxafil, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- J02AC04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 02/03/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NOXAFIL susp 105 ml
- Description (DE)
- NOXAFIL Susp 105 ml
- Market launch
- 02/03/2007
- Narcotic (BTM)
- No